(NP (NP-COOD (NP (NN Function)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (DT the) (JJ immune) (NN system))) (. .))
(S (NP-SBJ (NN NF-kappa) (NN B)) (VP (VBZ is) (NP-PRD (DT a) (JJ ubiquitous) (NN transcription) (NN factor))) (. .))
(S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ-26 (PRP$ its) (NNS properties)) (VP (VBP seem) (S (NP-SBJ-27 (-NONE- *-26)) (VP (TO to) (VP (VB be) (VP (ADVP (RBS most) (RB extensively)) (VBN exploited) (NP (-NONE- *-27)) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))))))))) (. .))
(SINV (PP-PRD-TPC-28 (IN Among) (NP (DT these) (NNS properties))) (VP (VBP are) (PP-PRD (-NONE- *T*-28))) (NP-SBJ-COOD (NP (NP (NP (NN NF-kappa) (NN B) (POS 's)) (JJ rapid) (JJ posttranslational) (NN activation)) (PP (IN in) (NN response) (TO to) (NP (JJ many) (JJ pathogenic) (NNS signals)))) (, ,) (NP (NP (PRP$ its) (JJ direct) (NN participation)) (PP (IN in) (NP (ADJP (JJ (nuclear cytoplasmic))) (NN signaling)))) (, ,) (CC and) (NP (PRP$ its) (NN potency) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (DT a) (JJ great) (NN variety)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBG encoding) (NP (ADJP (RB immunologically) (JJ relevant)) (NNS proteins))))))))))))) (. .))
(S (PP (IN In) (NP (NNS vertebrates))) (, ,) (NP-SBJ-29 (CD five) (JJ distinct) (NN DNA) (NN binding) (NNS subunits)) (VP (VBP are) (ADVP-TMP (RB currently)) (VP (VBN known) (NP (NP (-NONE- *-29)) (SBAR (WHNP-30 (WDT which)) (S (NP-SBJ-31 (-NONE- *T*-30)) (VP (MD might) (ADVP (RB extensively)) (VP (VB heterodimerize) (, ,) (S (NP-SBJ (-NONE- *-31)) (ADVP (RB thereby)) (VP (VBG forming) (NP (NP (NNS complexes)) (PP (IN with) (NP-COOD (NP (JJ distinct) (JJ transcriptional) (NN activity)) (, ,) (NP (NN DNA) (NN sequence) (NN specificity)) (, ,) (CC and) (NP (ADJP (NP-COOD (NP (NN cell) (NN type-)) (CC and) (NP (NN cell) (NN stage-))) (JJ specific)) (NN distribution)))))))))))))) (. .))
(S (NP-SBJ-32 (NP (DT The) (NN activity)) (PP (IN of) (NP (NN DNA) (NN binding) (NN NF-kappa) (NN B) (NNS dimers)))) (VP (VBZ is) (VP (ADVP (RB tightly)) (VBN controlled) (NP (-NONE- *-32)) (PP (IN by) (NP-LGS (NP (NN accessory) (NNS proteins)) (VP (VBN called) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN I) (NN kappa) (NN B) (NNS subunits)))) (SBAR (WHPP-33 (IN of) (WHNP (WDT which))) (S (NP-SBJ (EX there)) (VP (VBP are) (ADVP (RB also)) (NP-PRD (NP (CD five) (JJ different) (NNS species)) (PP (-NONE- *T*-33)) (VP (ADVP-TMP (RB currently)) (VBN known) (NP (-NONE- *)) (PP (IN in) (NP (NNS vertebrates)))))))))))) (. .))
(S (NP-SBJ (NN I) (NN kappa) (NN B) (NNS proteins)) (VP (VP-COOD (VP (VBP inhibit) (NP (NP (NN DNA) (NN binding)) (PP (-NONE- *RNR*-35)))) (CC and) (VP (VBP prevent) (NP (NP (JJ nuclear) (NN uptake)) (PP (-NONE- *RNR*-35))))) (PP-35 (IN of) (NP (NN NF-kappa) (NN B) (NNS complexes)))) (. .))
(S (NP-SBJ (DT An) (NN exception)) (VP (VBZ is) (NP-PRD (NP (DT the) (NN Bcl-3) (NN protein)) (SBAR (WHNP-36 (WDT which)) (S (PP (IN in) (NP (NN addition))) (NP-SBJ (-NONE- *T*-36)) (VP (MD can) (VP (VB function) (PP (IN as) (NP (DT a) (NN transcription) (NN activating) (NN subunit))) (PP (IN in) (NP (DT th) (NN nucleus))))))))) (. .))
(S (NP-SBJ-37 (JJ Other) (NN I) (NN kappa) (NN B) (NNS proteins)) (VP (VBP are) (VP (ADVP (RB rather)) (VBN involved) (NP-38 (-NONE- *-37)) (PP (IN in) (S (NP-SBJ (-NONE- *-38)) (VP (VBG terminating) (NP (NP (NP (NN NF-kappa) (NN B) (POS 's)) (NN activity)) (PP (IN in) (NP (DT the) (NN nucleus))))))))) (. .))
(S (NP-SBJ (NP (NP (DT The) (JJ intracellular) (NNS events)) (SBAR (WHNP-39 (WDT that)) (S (NP-SBJ (-NONE- *T*-39)) (VP (VBP lead) (PP (TO to) (NP (NP (DT the) (NN inactivation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B))))))))) (, ,) (NP (ADVP (FW i.e.)) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (, ,)) (VP (VBP are) (ADJP-PRD (JJ complex))) (. .))
(S (NP-SBJ-40 (PRP They)) (VP-COOD (VP (VBP involve) (NP-COOD (NP (NN phosphorylation)) (CC and) (NP (JJ proteolytic) (NNS reactions)))) (CC and) (VP (VBP seem) (S (NP-SBJ-41 (-NONE- *-40)) (VP (TO to) (VP (VB be) (VP (VBN controlled) (NP (-NONE- *-41)) (PP (IN by) (NP-LGS (NP (DT the) (NNS cells) (POS ')) (NN redox) (NN status))))))))) (. .))
(S (NP-SBJ (NP (NN Interference)) (PP (IN with) (NP (NP (DT the) (NP-COOD (NP (NN activation)) (CC or) (NP (NN activity)))) (PP (IN of) (NP (NN NF-kappa) (NN B)))))) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ beneficial)) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG suppressing) (NP-COOD (NP (ADJP (JJ (septic toxic))) (NN shock)) (, ,) (NP (JJ graft-vs-host) (NNS reactions)) (, ,) (NP (JJ acute) (JJ inflammatory) (NNS reactions)) (, ,) (NP (JJ acute) (NN phase) (NN response)) (, ,) (CC and) (NP (NN radiation) (NN damage)))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN inhibition)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN activation))) (PP (IN by) (NP-COOD (NP (NNS antioxidants)) (CC and) (NP (JJ specific) (NN protease) (NNS inhibitors))))) (VP (MD may) (VP (VB provide) (NP (NP (DT a) (JJ pharmacological) (NN basis)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG interfering) (PP (IN with) (NP (DT these) (JJ acute) (NNS processes))))))))) (. .))
